In 2K1C hypertensive rats, L-NAME decreased renal blood flow in the nonclipped kidney by 61% (P<0.001), whereas losartan reduced blood pressure and normalized blood flow in the clipped kidney.
Does angiotensin II antagonism with losartan alter the renal hemodynamic response to nitric oxide synthesis inhibition in 2K1C renovascular hypertensive rats?
The study demonstrates significant interactions between endothelium-derived nitric oxide and angiotensin II in regulating bilateral renal blood flow in renovascular hypertension.
In two-kidney, one clip (2K1C) renovascular hypertension, blood flow is reduced to the clipped but not to the nonclipped kidney, despite elevated angiotensin II. To determine possible interactions between endothelium-derived nitric oxide and angiotensin, we studied bilateral renal blood flow using radioactive microspheres in anesthetized 2K1C hypertensive rats 4 weeks after clipping. We studied the response to nitric oxide synthesis inhibition with 10 mg/kg body wt NG-nitro-L-arginine- methyl ester (L-NAME) in hypertensive rats untreated (n = 5) or treated (n = 5) with 10 mg/kg body wt of the angiotensin II antagonist losartan. 2K1C rats had a blood pressure of 159 +/- 9 mm Hg, and renal blood flow to the clipped kidney was reduced 87% compared with the nonclipped kidney. L-NAME increased blood pressure 36 +/- 5 mm Hg and decreased renal blood flow in the nonclipped kidney 61% (4.9 +/- 0.5 to 1.9 +/- 0.4 mL/min per gram kidney weight, P < .001). Renal vascular resistance increased 200% (33.4 +/- 2.2 to 100.7 +/- 15.0 resistance units RU, P < .005). Renal blood flow and resistance in the clipped kidney were unchanged by L-NAME. Treatment of 2K1C rats with losartan reduced blood pressure (154 +/- 8 to 116 +/- 11 mm Hg, P < .01), did not change blood flow in the nonclipped, but normalized it in the clipped kidney (4.8 +/- 0.8 mL/min per gram kidney weight).(ABSTRACT TRUNCATED AT 250 WORDS)
Sigmon et al. (Sun,) conducted a other in Renovascular hypertension (n=10). L-NAME (with or without losartan) vs. Untreated (no losartan) was evaluated on Bilateral renal blood flow and blood pressure. In 2K1C hypertensive rats, L-NAME decreased renal blood flow in the nonclipped kidney by 61% (P<0.001), whereas losartan reduced blood pressure and normalized blood flow in the clipped kidney.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: